Your browser doesn't support javascript.
loading
Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma.
Shohdy, Kyrillus S; Villamar, Dario M; Cao, Yen; Trieu, Janson; Price, Kristin S; Nagy, Rebecca; Tagawa, Scott T; Molina, Ana M; Sternberg, Cora N; Nanus, David M; Mosquera, Juan Miguel; Elemento, Olivier; Sonpavde, Guru P; Grivas, Petros; Vogelzang, Nicholas J; Faltas, Bishoy Morris.
Affiliation
  • Shohdy KS; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Villamar DM; Department of Clinical Oncology, Kasr Alainy School of Medicine, Cairo University, Cairo, Egypt.
  • Cao Y; Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Trieu J; Department of Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA.
  • Price KS; Department of Medical Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA.
  • Nagy R; Guardant Health, Inc, Redwood City, CA, USA.
  • Tagawa ST; Guardant Health, Inc, Redwood City, CA, USA.
  • Molina AM; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Sternberg CN; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Nanus DM; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Mosquera JM; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Elemento O; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Sonpavde GP; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Grivas P; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Vogelzang NJ; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Faltas BM; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
Br J Cancer ; 126(3): 430-439, 2022 02.
Article de En | MEDLINE | ID: mdl-35046520

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la vessie urinaire / Carcinome transitionnel / Marqueurs biologiques tumoraux / Médecine de précision / ADN tumoral circulant / Mutation Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Br J Cancer Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la vessie urinaire / Carcinome transitionnel / Marqueurs biologiques tumoraux / Médecine de précision / ADN tumoral circulant / Mutation Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Br J Cancer Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique